Context-Aware Process Modelling for Medicinal Product Development - The Practice of Enterprise Modeling Access content directly
Conference Papers Year : 2021

Context-Aware Process Modelling for Medicinal Product Development

Abstract

Advanced Therapy Medicinal Products (ATMPs) are highly innovative medicinal products that are based on biomedical technology. ATMP development processes need to comply with complex regulatory frameworks. Currently, biomedical scientists that develop ATMPs manage the regulatory aspects of the ATMP development processes in an ad-hoc fashion, resulting in inefficiencies such as rework, or even withdrawal of ATMPs from the market if the regulatory requirements are not adequately addressed. This paper presents an explorative case study in which we investigate enterprise modelling and context-aware business processes to support ATMP scientists in managing the regulatory aspects of ATMP development processes more efficiently and effectively. The main objective of this case study is to offer regulatory-based guidance to scientists. We use enterprise models (domain, goal and process models) to describe the important concepts and views in ATMP development processes. By introducing context-awareness to the models, we enable regulatory-based guidance that supports ATMP scientists in performing relevant tasks to address the regulatory requirements efficiently and effectively.
Fichier principal
Vignette du fichier
514409_1_En_12_Chapter.pdf (2.65 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-04323850 , version 1 (05-12-2023)

Licence

Attribution

Identifiers

Cite

Zeynep Ozturk Yurt, Rik Eshuis, Anna Wilbik, Irene Vanderfeesten. Context-Aware Process Modelling for Medicinal Product Development. 14th IFIP Working Conference on The Practice of Enterprise Modeling (PoEM), Nov 2021, Riga, Latvia. pp.168-183, ⟨10.1007/978-3-030-91279-6_12⟩. ⟨hal-04323850⟩
14 View
4 Download

Altmetric

Share

Gmail Facebook X LinkedIn More